169 related articles for article (PubMed ID: 14729108)
1. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1 mRNA inhibits neointima formation in rat carotid artery after balloon injury.
Ando H; Fukuda N; Kotani M; Yokoyama Si; Kunimoto S; Matsumoto K; Saito S; Kanmatsuse K; Mugishima H
Eur J Pharmacol; 2004 Jan; 483(2-3):207-14. PubMed ID: 14729108
[TBL] [Abstract][Full Text] [Related]
2. Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury.
Kotani M; Fukuda N; Ando H; Hu WY; Kunimoto S; Saito S; Kanmatsuse K
Cardiovasc Res; 2003 Jan; 57(1):265-76. PubMed ID: 12504837
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-encoded hammerhead ribozyme to PDGF A-chain mRNA inhibits neointima formation after arterial injury.
Lin ZH; Fukuda N; Suzuki R; Takagi H; Ikeda Y; Saito S; Matsumoto K; Kanmatsuse K; Mugishima H
J Vasc Res; 2004; 41(4):305-13. PubMed ID: 15192266
[TBL] [Abstract][Full Text] [Related]
4. DNA-RNA chimeric hammerhead ribozyme to transforming growth factor-beta(1) mRNA inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats.
Teng J; Fukuda N; Hu WY; Nakayama M; Kishioka H; Kanmatsuse K
Cardiovasc Res; 2000 Oct; 48(1):138-47. PubMed ID: 11033116
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
[TBL] [Abstract][Full Text] [Related]
6. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
Tahira Y; Fukuda N; Endo M; Ueno T; Matsuda H; Saito S; Matsumoto K; Mugishima H
J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of growth of human gingival fibroblasts by chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1.
Yusa J; Fukuda N; Sato S; Matsmoto K; Mugishima H; Kamoi K
J Periodontol; 2005 Aug; 76(8):1265-74. PubMed ID: 16101357
[TBL] [Abstract][Full Text] [Related]
8. Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.
Lan W; Yang F; Li Z; Liu L; Sang H; Jiang Y; Xiong Y; Zhang R
J Vasc Surg; 2016 Oct; 64(4):1074-83. PubMed ID: 26054589
[TBL] [Abstract][Full Text] [Related]
9. Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease.
Yamamoto K; Morishita R; Tomita N; Shimozato T; Nakagami H; Kikuchi A; Aoki M; Higaki J; Kaneda Y; Ogihara T
Circulation; 2000 Sep; 102(11):1308-14. PubMed ID: 10982548
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme to human TGF-beta1 mRNA inhibits the proliferation of human vascular smooth muscle cells.
Su JZ; Fukuda N; Hu WY; Kanmatsuse K
Biochem Biophys Res Commun; 2000 Nov; 278(2):401-7. PubMed ID: 11097849
[TBL] [Abstract][Full Text] [Related]
11. A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery.
Yao EH; Fukuda N; Ueno T; Matsuda H; Nagase H; Matsumoto Y; Sugiyama H; Matsumoto K
Cardiovasc Res; 2009 Mar; 81(4):797-804. PubMed ID: 19098300
[TBL] [Abstract][Full Text] [Related]
12. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.
Smith JD; Bryant SR; Couper LL; Vary CP; Gotwals PJ; Koteliansky VE; Lindner V
Circ Res; 1999 May; 84(10):1212-22. PubMed ID: 10347096
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
Ward MR; Sasahara T; Agrotis A; Dilley RJ; Jennings GL; Bobik A
Atherosclerosis; 1998 Apr; 137(2):267-75. PubMed ID: 9622270
[TBL] [Abstract][Full Text] [Related]
14. Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation.
Blalock TD; Yuan R; Lewin AS; Schultz GS
Exp Eye Res; 2004 Jun; 78(6):1127-36. PubMed ID: 15109919
[TBL] [Abstract][Full Text] [Related]
15. Effect of TGF-beta(1) antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglycans in balloon catheter-injured neointima of rabbit carotid arteries.
Merrilees M; Beaumont B; Scott L; Hermanutz V; Fennessy P
J Vasc Res; 2000; 37(1):50-60. PubMed ID: 10720886
[TBL] [Abstract][Full Text] [Related]
16. Ribozyme-mediated inhibition of rat leukocyte-type 12-lipoxygenase prevents intimal hyperplasia in balloon-injured rat carotid arteries.
Gu JL; Pei H; Thomas L; Nadler JL; Rossi JJ; Lanting L; Natarajan R
Circulation; 2001 Mar; 103(10):1446-52. PubMed ID: 11245651
[TBL] [Abstract][Full Text] [Related]
17. Bis (aspirinato) zinc (II) complex successfully inhibits carotid arterial neointima formation after balloon-injury in rats.
Hegedűs P; Korkmaz S; Radovits T; Schmidt H; Li S; Yoshikawa Y; Yasui H; Merkely B; Karck M; Szabó G
Cardiovasc Drugs Ther; 2014 Dec; 28(6):533-9. PubMed ID: 25129612
[TBL] [Abstract][Full Text] [Related]
18. Production of transforming growth factor beta 1 during repair of arterial injury.
Majesky MW; Lindner V; Twardzik DR; Schwartz SM; Reidy MA
J Clin Invest; 1991 Sep; 88(3):904-10. PubMed ID: 1832175
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vascular smooth muscle cell proliferation by DNA-RNA chimeric hammerhead ribozyme targeting to rat platelet-derived growth factor A-chain mRNA.
Hu WY; Fukuda N; Nakayama M; Kishioka H; Kanmatsuse K
J Hypertens; 2001 Feb; 19(2):203-12. PubMed ID: 11212962
[TBL] [Abstract][Full Text] [Related]
20. Hammerhead ribozyme targeting human platelet-derived growth factor A-chain mRNA inhibited the proliferation of human vascular smooth muscle cells.
Hu WY; Fukuda N; Kishioka H; Nakayama M; Satoh C; Kanmatsuse K
Atherosclerosis; 2001 Oct; 158(2):321-9. PubMed ID: 11583710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
